Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
Quick Stats
Jan 30, 202652.7
AI Score
HOLD0.49
Volume Ratio
Next Earnings
11
+ve Days (30d)
18
-ve Days (30d)
MBIO Stock Summary
Last updated Jan 30, 2026
MBIO is currently trading at $0.965, positioned below its 200-day moving average of $1.41, suggesting bearish momentum. The stock has a 52-week range of $0.893 to $7.
Technical Analysis: The 50-day moving average stands at $1.12, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 36.386, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.312, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates MBIO at 52.7/100 with a HOLD recommendation.
MBIO (Mustang Bio, Inc.) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 36.386 |
| CMF (20) | -0.312 |
| ROC (10) | -8.095 |
| ADX (14) | 16.378 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.037 |
| AROONOSC (14) | -92.857 |
| WILLAMS %R (14) | -97.666 |
| MFI (14) | 11.429 |
MBIO Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
MBIO Price vs Max Options Open Interest
MBIO Max Change In Options Open Interest
MBIO Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MBIO Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MBIO Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MBIO Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Mustang Bio, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
MBIO Moving Averages Analysis
MBIO (Mustang Bio, Inc.) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 1.02 |
| 20 | 1.06 |
| 30 | 1.05 |
| 50 | 1.12 |
| 100 | 1.31 |
| 200 | 1.41 |
MBIO Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 7.1 million |
| Earnings/Share ($) | -6.71 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -17.5 |
| EPS Estimate Next Year ($) | 0 |
| WallStreet Target Price ($) | 10 |
| Most Recent Quarter |